1
|
Santalucia R, Carapancea E, Vespa S, Germany Morrison E, Ghasemi Baroumand A, Vrielynck P, Fierain A, Joris V, Raftopoulos C, Duprez T, Ferrao Santos S, van Mierlo P, El Tahry R. Clinical added value of interictal automated electrical source imaging in the presurgical evaluation of MRI-negative epilepsy: A real-life experience in 29 consecutive patients. Epilepsy Behav 2023; 143:109229. [PMID: 37148703 DOI: 10.1016/j.yebeh.2023.109229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 04/09/2023] [Accepted: 04/20/2023] [Indexed: 05/08/2023]
Abstract
OBJECTIVE During the presurgical evaluation, manual electrical source imaging (ESI) provides clinically useful information in one-third of the patients but it is time-consuming and requires specific expertise. This prospective study aims to assess the clinical added value of a fully automated ESI analysis in a cohort of patients with MRI-negative epilepsy and describe its diagnostic performance, by evaluating sublobar concordance with stereo-electroencephalography (SEEG) results and surgical resection and outcome. METHODS All consecutive patients referred to the Center for Refractory Epilepsy (CRE) of St-Luc University Hospital (Brussels, Belgium) for presurgical evaluation between 15/01/2019 and 31/12/2020 meeting the inclusion criteria, were recruited to the study. Interictal ESI was realized on low-density long-term EEG monitoring (LD-ESI) and, whenever available, high-density EEG (HD-ESI), using a fully automated analysis (Epilog PreOp, Epilog NV, Ghent, Belgium). The multidisciplinary team (MDT) was asked to formulate hypotheses about the epileptogenic zone (EZ) location at sublobar level and make a decision on further management for each patient at two distinct moments: i) blinded to ESI and ii) after the presentation and clinical interpretation of ESI. Results leading to a change in clinical management were considered contributive. Patients were followed up to assess whether these changes lead to concordant results on stereo-EEG (SEEG) or successful epilepsy surgery. RESULTS Data from all included 29 patients were analyzed. ESI led to a change in the management plan in 12/29 patients (41%). In 9/12 (75%), modifications were related to a change in the plan of the invasive recording. In 8/9 patients, invasive recording was performed. In 6/8 (75%), the intracranial EEG recording confirmed the localization of the ESI at a sublobar level. So far, 5/12 patients, for whom the management plan was changed after ESI, were operated on and have at least one-year postoperative follow-up. In all cases, the EZ identified by ESI was included in the resection zone. Among these patients, 4/5 (80%) are seizure-free (ILAE 1) and one patient experienced a seizure reduction of more than 50% (ILAE 4). CONCLUSIONS In this single-center prospective study, we demonstrated the added value of automated ESI in the presurgical evaluation of MRI-negative cases, especially in helping to plan the implantation of depth electrodes for SEEG, provided that ESI results are integrated into the whole multimodal evaluation and clinically interpreted.
Collapse
Affiliation(s)
- Roberto Santalucia
- Cliniques Universitaires Saint-Luc, Paediatric Neurology Unit, Brussels, Belgium; Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium; Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium.
| | - Evelina Carapancea
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium
| | - Simone Vespa
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium
| | - Enrique Germany Morrison
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium
| | - Amir Ghasemi Baroumand
- Medical Image and Signal Processing, Ghent University, Ghent, Belgium; Epilog NV, Ghent, Belgium
| | - Pascal Vrielynck
- Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium
| | - Alexane Fierain
- Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium
| | - Vincent Joris
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Neurosurgery Unit, Brussels, Belgium
| | - Christian Raftopoulos
- Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Neurosurgery Unit, Brussels, Belgium
| | - Thierry Duprez
- Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Medical Imaging Department, Neuroradiology Unit, Belgium
| | - Susana Ferrao Santos
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium
| | - Pieter van Mierlo
- Medical Image and Signal Processing, Ghent University, Ghent, Belgium; Epilog NV, Ghent, Belgium
| | - Riëm El Tahry
- Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCL), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium; WELBIO Department, WEL Research Institute, Avenue Pasteur 6, 1300 Wavre, Belgium
| |
Collapse
|